Response to Comments: Molecular Pathology Procedures

This document is a response-to-comments notice regarding the Molecular Pathology Procedures LCD and does not itself specify clinical coverage criteria. It announces the official notice period beginning June 13, 2024, with the final determination becoming effective August 1, 2024; no indications, limitations, documentation, or frequency rules are provided in this notice.